BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29597309)

  • 1. Emerging Non-Canonical Functions and Regulation of p53.
    Ranjan A; Iwakuma T
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29597309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the p53 cistrome--DNA binding cooperativity dissects p53's tumor suppressor functions.
    Schlereth K; Heyl C; Krampitz AM; Mernberger M; Finkernagel F; Scharfe M; Jarek M; Leich E; Rosenwald A; Stiewe T
    PLoS Genet; 2013; 9(8):e1003726. PubMed ID: 23966881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-translational modifications of p53 tumor suppressor: determinants of its functional targets.
    Taira N; Yoshida K
    Histol Histopathol; 2012 Apr; 27(4):437-43. PubMed ID: 22374721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into p53 functions through its target microRNAs.
    Liao JM; Cao B; Zhou X; Lu H
    J Mol Cell Biol; 2014 Jun; 6(3):206-13. PubMed ID: 24740682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RASSF6 Tumor Suppressor Protein Regulates Apoptosis and Cell Cycle Progression via Retinoblastoma Protein.
    Hossain S; Iwasa H; Sarkar A; Maruyama J; Arimoto-Matsuzaki K; Hata Y
    Mol Cell Biol; 2018 Sep; 38(17):. PubMed ID: 29891515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in p53.
    D'Orazi G
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33546313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor p53 and its mutants in cancer metabolism.
    Liu J; Zhang C; Hu W; Feng Z
    Cancer Lett; 2015 Jan; 356(2 Pt A):197-203. PubMed ID: 24374014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging links between E2F control and mitochondrial function.
    Benevolenskaya EV; Frolov MV
    Cancer Res; 2015 Feb; 75(4):619-23. PubMed ID: 25634216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Context is key: Understanding the regulation, functional control, and activities of the p53 tumour suppressor.
    Moxley AH; Reisman D
    Cell Biochem Funct; 2021 Mar; 39(2):235-247. PubMed ID: 32996618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of DNA damage responses in p53 biology.
    Speidel D
    Arch Toxicol; 2015 Apr; 89(4):501-17. PubMed ID: 25618545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and function of p53: A perspective from Drosophila studies.
    Ingaramo MC; Sánchez JA; Dekanty A
    Mech Dev; 2018 Dec; 154():82-90. PubMed ID: 29800619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ubiquitin peptidase UCHL1 induces G0/G1 cell cycle arrest and apoptosis through stabilizing p53 and is frequently silenced in breast cancer.
    Xiang T; Li L; Yin X; Yuan C; Tan C; Su X; Xiong L; Putti TC; Oberst M; Kelly K; Ren G; Tao Q
    PLoS One; 2012; 7(1):e29783. PubMed ID: 22279545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Balancing Act: p53 Activity from Tumor Suppression to Pathology and Therapeutic Implications.
    Wang M; Attardi LD
    Annu Rev Pathol; 2022 Jan; 17():205-226. PubMed ID: 34699262
    [No Abstract]   [Full Text] [Related]  

  • 14. Silencing of mutant p53 by siRNA induces cell cycle arrest and apoptosis in human bladder cancer cells.
    Zhu HB; Yang K; Xie YQ; Lin YW; Mao QQ; Xie LP
    World J Surg Oncol; 2013 Jan; 11():22. PubMed ID: 23356234
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Ezerskyte M; Paredes JA; Malvezzi S; Burns JA; Margison GP; Olsson M; Scicchitano DA; Dreij K
    Proc Natl Acad Sci U S A; 2018 May; 115(18):4731-4736. PubMed ID: 29666243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mitochondrial p53 pathway.
    Vaseva AV; Moll UM
    Biochim Biophys Acta; 2009 May; 1787(5):414-20. PubMed ID: 19007744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription pattern of p53-targeted DNA repair genes in the hypoxia-tolerant subterranean mole rat Spalax.
    Shams I; Malik A; Manov I; Joel A; Band M; Avivi A
    J Mol Biol; 2013 Apr; 425(7):1111-8. PubMed ID: 23318952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor p53 and its gain-of-function mutants in cancer.
    Liu J; Zhang C; Feng Z
    Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):170-9. PubMed ID: 24374774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unravelling mechanisms of p53-mediated tumour suppression.
    Bieging KT; Mello SS; Attardi LD
    Nat Rev Cancer; 2014 May; 14(5):359-70. PubMed ID: 24739573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy.
    Zhang DG; Zheng JN; Pei DS
    Mol Cancer; 2014 May; 13():115. PubMed ID: 24884974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.